These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 38336265)
1. Statewide efforts to address the opioid epidemic: Results from a national survey of single state agencies. Estrada MAG; Abraham AJ; Andrews CM; Grogan CM J Subst Use Addict Treat; 2024 May; 160():209309. PubMed ID: 38336265 [TBL] [Abstract][Full Text] [Related]
2. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018. Lee B; Zhao W; Yang KC; Ahn YY; Perry BL JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816 [TBL] [Abstract][Full Text] [Related]
3. Naloxone's role in the national opioid crisis-past struggles, current efforts, and future opportunities. Bennett AS; Elliott L Transl Res; 2021 Aug; 234():43-57. PubMed ID: 33684591 [TBL] [Abstract][Full Text] [Related]
4. Local health departments and the implementation of evidence-based policies to address opioid overdose mortality. Feuerstein-Simon R; Lowenstein M; Sharma M; Dupuis R; Luna Marti X; Cannuscio CC Subst Abus; 2020; 41(4):468-474. PubMed ID: 32213045 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of medications used for opioid use disorder in emergency departments: A cross-sectional analysis of the 2020 National Hospital Ambulatory Medical Care Survey. Lee S; Sun L; Vakkalanka JP Am J Emerg Med; 2024 Aug; 82():52-56. PubMed ID: 38795424 [TBL] [Abstract][Full Text] [Related]
6. Promoting sustainable responses to the US opioid epidemic with community-academic partnerships: qualitative outcomes from a statewide program. Driscoll DL; Cuellar AE; Agarwal V; Jones D; Dunkenberger MB; Hosig K Subst Abuse Treat Prev Policy; 2022 Apr; 17(1):26. PubMed ID: 35392939 [TBL] [Abstract][Full Text] [Related]
7. Deploying science to change hearts and minds: Responding to the opioid crisis. Walsh SL; Long KQX Prev Med; 2019 Nov; 128():105780. PubMed ID: 31319116 [TBL] [Abstract][Full Text] [Related]
8. The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders. Reif S; Brolin MF; Stewart MT; Fuchs TJ; Speaker E; Mazel SB J Subst Abuse Treat; 2020 Jan; 108():33-39. PubMed ID: 31358328 [TBL] [Abstract][Full Text] [Related]
9. Perception of Resource Allocations to Address the Opioid Epidemic. Strickland JC; Victor G; Ray B J Addict Med; 2022 Sep-Oct 01; 16(5):563-569. PubMed ID: 36201678 [TBL] [Abstract][Full Text] [Related]
10. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study. Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372 [TBL] [Abstract][Full Text] [Related]
11. Expanding Access to Naloxone: A Necessary Step to Curb the Opioid Epidemic. Houser R Disaster Med Public Health Prep; 2022 Sep; 17():e245. PubMed ID: 36172901 [TBL] [Abstract][Full Text] [Related]
12. Allocation of federal funding to address the opioid overdose crisis in the criminal legal system. Harris SJ; Abraham AJ; Lozano-Rojas F; Negaro S; Andrews CM; Grogan CM J Subst Use Addict Treat; 2023 Jul; 150():209064. PubMed ID: 37156423 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids. Winhusen T; Wilder C; Lyons MS; Theobald J; Kropp F; Lewis D Drug Alcohol Depend; 2020 Nov; 216():108265. PubMed ID: 32919098 [TBL] [Abstract][Full Text] [Related]
14. Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose. Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM JAMA Intern Med; 2024 Aug; 184(8):954-962. PubMed ID: 38884975 [TBL] [Abstract][Full Text] [Related]
15. An economic analysis of the cost of mobile units for harm reduction, naloxone distribution, and medications for opioid use disorder. Castry M; Tin Y; Feder NM; Lewis N; Chatterjee A; Rudorf M; Samet JH; Beers D; Medley B; Gilbert L; Linas BP; Barocas JA J Subst Use Addict Treat; 2024 Dec; 167():209517. PubMed ID: 39299504 [TBL] [Abstract][Full Text] [Related]
16. Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system. Rawson RA; Rieckmann T; Cousins S; McCann M; Pearce R Prev Med; 2019 Nov; 128():105785. PubMed ID: 31362002 [TBL] [Abstract][Full Text] [Related]
17. State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder. Abraham AJ; Andrews CM; Grogan CM; Pollack HA; D'Aunno T; Humphreys K; Friedmann PD Psychiatr Serv; 2018 Apr; 69(4):448-455. PubMed ID: 29241428 [TBL] [Abstract][Full Text] [Related]
18. Three Cooperative Extension initiatives funded to address Michigan's opioid crisis. Eschbach CL; Contreras DA; Kennedy LE Front Public Health; 2022; 10():921919. PubMed ID: 36203707 [TBL] [Abstract][Full Text] [Related]
19. Projected Estimates of Opioid Mortality After Community-Level Interventions. Linas BP; Savinkina A; Madushani RWMA; Wang J; Eftekhari Yazdi G; Chatterjee A; Walley AY; Morgan JR; Epstein RL; Assoumou SA; Murphy SM; Schackman BR; Chrysanthopoulou SA; White LF; Barocas JA JAMA Netw Open; 2021 Feb; 4(2):e2037259. PubMed ID: 33587136 [TBL] [Abstract][Full Text] [Related]
20. Where Opioid Overdose Patients Live Far From Treatment: Geospatial Analysis of Underserved Populations in New York State. Abell-Hart K; Rashidian S; Teng D; Rosenthal RN; Wang F JMIR Public Health Surveill; 2022 Apr; 8(4):e32133. PubMed ID: 35412467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]